Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Goldman Sachs analyst James Quigley initiated coverage on Sanofi SNY with a Neutral rating and announced a price target of $65. Sanofi shares closed at $57.79 on Thursday. See how other analysts view this stock.
- Raymond James analyst Daniel Tamayo initiated coverage on ACNB Corporation ACNB with an Outperform rating and announced a price target of $47. ACNB shares closed at $41.25 on Thursday. See how other analysts view this stock.
- B. Riley Securities analyst Nick Giles initiated coverage on United States Antimony Corporation UAMY with a Buy rating and announced a price target of $3. United States Antimony shares closed at $1.79 on Thursday. See how other analysts view this stock.
- Maxim Group analyst Jason McCarthy initiated coverage on Anixa Biosciences, Inc. ANIX with a Buy rating and announced a price target of $1. Anixa Biosciences shares closed at $3.15 on Thursday. See how other analysts view this stock.
Considering buying ACNB stock? Here’s what analysts think:
Read This Next:
Momentum71.95
Growth59.04
Quality30.55
Value–
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
